ACLID
Aclid is a biotechnology security and compliance automation platform. Aclid is used by gene synthesis companies to verify customers, screen DNA and RNA orders for pathogenic and hazardous elements, and automate compliance inspections.
ACLID
Industry:
Biopharma Biotechnology Life Science
Founded:
2021-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.aclid.bio
Total Employee:
1+
Status:
Active
Total Funding:
3.3 M USD
Technology used in webpage:
Domain Not Resolving Amazon Cloudflare Hosting Amazon Virginia Region Amazon Cognito
Investors List
IA Ventures
IA Ventures investment in Seed Round - Aclid
2048 Ventures
2048 Ventures investment in Seed Round - Aclid
2048 Ventures
2048 Ventures investment in Pre Seed Round - Aclid
Official Site Inspections
http://www.aclid.bio
- Host name: 104.26.6.13
- IP address: 104.26.6.13
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aclid"
Aclid | Gene Synthesis Security and Compliance
Automate compliance with real-time screening and customer verification. HOW DOES ACLID WORK? Rich threat assessments and risk profiles delivered in seconds for hundreds of …See details»
Aclid | Gene Synthesis Security and Compliance
Built by pioneers in biosecurity and synthetic biology. Aclid was founded in 2021, in the wake of a pandemic and record-breaking growth of synthetic biology. Biological security was becoming essential, but we knew how hard it could be …See details»
Aclid | Gene Synthesis Security and Compliance
Screen DNA and RNA for controlled pathogenic or toxic elements. Automate compliance follow ups with your customers and verify credentials. Centralize all your biosecurity data to stay compliant with reporting requirements. The …See details»
Aclid - Crunchbase Company Profile & Funding
Aclid is a biotechnology security and compliance automation platform. Aclid is used by gene synthesis companies to verify customers, screen DNA and RNA …See details»
Aclid, Inc. - EBRC
Oct 20, 2022 · Aclid is a security and safety platform for synthetic biology founded by Professor Harris Wang at Columbia University. We provide a tech-enabled service that identifies …See details»
Home | International Gene Synthesis Consortium
Aclid. Aclid was founded to advance responsible research in synthetic biology. The company's platform is an end-to-end solution for screening DNA sequences and customers.See details»
Aclid - LinkedIn
Aclid helps scientists build safer and better biomanufactured products. The world's leading biotech manufacturers and governments rely on Aclid's security and safety products for responsible...See details»
Aclid Closes Oversubscribed $3.3 Million Seed Funding …
Oct 12, 2023 · Aclid is the security and compliance automation platform for biotechnology. Gene synthesis providers use Aclid to verify customers, screen DNA and RNA orders for pathogenic and...See details»
Aclid Company Profile 2024: Valuation, Funding
Developer of a security and compliance automation platform designed for biotechnology.See details»
A biosecurity platform for the identification of natural and …
Aclid is the only end-to-end DNA screening platform in existence. Users can gain necessary bioinformation on each use, including organism name, gene ontology, virulence, and function. …See details»
Aclid | Gene Synthesis Security and Compliance
New US federal funding requirements go into effect October 24, 2024. Read our guide to complying with the White House's Framework for Nucleic Acid Synthesis Screening →.See details»
Aclid - Biotech Careers
Aclid is a security and safety platform for synthetic biology. The company's DNA screening solution for biosecurity, export control compliance, and EH&S keeps researchers safe and …See details»
Aclid closes $3.3m seed funding to advance biosecurity and …
Aclid, the security and compliance automation platform for the biotechnology industry, announced it closed an oversubscribed seed financing of $3.3 million. The funding will enable Aclid to …See details»
In a Win for Biosecurity, Aclid Secures $3.3M in Seed Funding
Oct 12, 2023 · Aclid, a platform designed to automate security and compliance for the biotech industry, has just announced a successful seed financing round, raking in a whopping $3.3 …See details»
Aclid - Products, Competitors, Financials, Employees, Headquarters ...
Aclid specializes in gene synthesis security and compliance within the biotechnology sector. The company offers an end-to-end biosecurity platform that provides screening and automatic …See details»
Nucleic acid synthesis screening guide - aclid.bio
With Aclid, you can streamline your screening process and automate more than 80% of the work. Here’s what automated screening looks like: Integrate your ordering platform and internal …See details»
Aclid Closes Oversubscribed $3.3 Million Seed Funding Round to …
Oct 12, 2023 · Aclid, the security and compliance automation platform for the biotechnology industry, today announced it closed an oversubscribed seed financing of $3.3 million.See details»
Aclid Closes Oversubscribed $3.3 Million Seed Funding Round to …
Aclid is the security and compliance automation platform for biotechnology. Gene synthesis providers use Aclid to verify customers, screen DNA and RNA orders for pathogenic and toxic …See details»
Biotechnology Innovation Organization | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
Aclid | Press Release
Oct 12, 2023 · Aclid is the security and compliance automation platform for biotechnology. Gene synthesis providers use Aclid to verify customers, screen DNA and RNA orders for pathogenic …See details»